Learning Objectives
Master the clinical utility and specific associations of Serum Tumor Markers. Understand their role in monitoring recurrence and response to therapy, while recognizing the necessity of biopsy for definitive diagnosis and the potential for elevations in non-neoplastic conditions.
1. Clinical Utility & Limitations
Tumor markers are rarely used as a primary diagnostic tool. Their main value lies in tracking a known cancer’s behavior over time.
| Clinical Use | Important Caveats |
|---|---|
| Monitoring | Used to detect tumor recurrence and evaluate response to therapy. |
| Diagnosis | Definitive diagnosis must be made via tissue biopsy. |
| Specificity | Many markers are associated with non-neoplastic conditions (e.g., PSA in BPH). |
2. Germ Cell & Fetal-Derived Markers
These markers are often associated with tumors that recapitulate embryonic or placental tissue.
| Marker | Important Associations | Notes |
|---|---|---|
| AFP (α-fetoprotein) | Hepatocellular carcinoma, Yolk sac (endodermal sinus) tumor, Ataxia-telangiectasia. | High in Neural Tube Defects; Low in Down Syndrome. |
| hCG | Choriocarcinoma, Hydatidiform moles, Testicular cancer. | Produced by syncytiotrophoblasts of the placenta. |
| LDH | Testicular germ cell tumors, Ovarian dysgerminoma. | Indicator of general tumor burden. |
Activity:
3. Organ-Specific & Glandular Markers
Most “CA” (Cancer Antigen) markers are used to follow adenocarcinomas in specific organs.
| Target Organ | Marker | Key Details |
|---|---|---|
| Prostate | PSA | Elevated in BPH and prostatitis. |
| Pancreas | CA 19-9 (also CEA) | Used for pancreatic adenocarcinoma monitoring. |
| Ovary | CA 125 | Specific for epithelial ovarian cancer. |
| Breast | CA 15-3 / CA 27-29 | Monitoring for recurrence. |
| Colorectal | CEA | Very nonspecific CarcinoEmbryonic Antigen. |
4. Neuroendocrine & Bone Markers
These markers indicate the functional lineage of the tumor or its impact on distant tissues.
| Marker | Clinical Association | Clinical Correlation |
|---|---|---|
| Alkaline Phosphatase | Metastases to bone/liver, Paget disease, Seminoma (PLAP). | Check GGT to rule out hepatic origin. |
| Chromogranin & NSE | Neuroendocrine tumors (Small cell lung cancer, Carcinoid). | NSE = Neuron-specific enolase. |
| Calcitonin | Medullary thyroid carcinoma. | Think Calci2nin for MEN 2A/2B. |
Activity
High-Yield Mnemonics & Tips:
- AFP Trends: In prenatal screening, think of the “Highs and Lows.” High AFP = Neural Tube/Abdominal Wall Defects. Low AFP = Down Syndrome.
- The “CA” Numbers: CA 125 is for Ovarian (the 5 looks like an ‘S’ for ‘Surface epithelium’). CA 19-9 is for Pancreas. CA 15-3 is for Breast (15 looks like ‘B’).
- GGT Rule: If Alk Phos is high, always check GGT. If GGT is normal, the Alk Phos is likely from Bone. If both are high, it’s likely Liver/Biliary.